These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4157 related articles for article (PubMed ID: 6892196)

  • 1. [Antitumor activity of cis-dichlorodiammineplatinum(II) and its effect on cell cycle progression].
    Takahashi K; Ebihara K; Honda Y; Nishikawa K; Kita M; Oomura M; Shibasaki C
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):624-31. PubMed ID: 6892196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethality, DNA alkylation, and cell cycle effects of adozelesin (U-73975) on rodent and human cells.
    Bhuyan BK; Smith KS; Adams EG; Petzold GL; McGovren JP
    Cancer Res; 1992 Oct; 52(20):5687-92. PubMed ID: 1394193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytokinetic response of human colon cancer cells to cis-dichlorodiammineplatinum(II).
    Bergerat JP; Barlogie B; Göhde W; Johnston DA; Drewinko B
    Cancer Res; 1979 Nov; 39(11):4356-63. PubMed ID: 498069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cis-diammino-dichloro-platinum (II) on cell growth and cell cycle progression of a mouse ascites tumor growing in vivo.
    Lewin F; Skog S; Tribukait B; Ringborg U
    In Vivo; 1989; 3(4):237-42. PubMed ID: 2519858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
    Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F
    Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferation kinetics of Ehrlich ascites tumors during cisplatin administration].
    Krug H; Taubert G; Lenschow S
    Acta Histochem Suppl; 1990; 39():61-5. PubMed ID: 2080294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
    Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS
    Cancer Res; 1997 Sep; 57(17):3759-64. PubMed ID: 9288784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 7-R-O-methylnogarol (menogaril) on L1210 cell progression in vitro and in vivo.
    Adams EG; Bhuyan BK
    Cancer Res; 1986 Dec; 46(12 Pt 1):6125-30. PubMed ID: 2946401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of cis-dichlorodiammineplatinum(II).
    Wolpert-DeFilippes MK
    Cancer Treat Rep; 1979; 63(9-10):1453-8. PubMed ID: 498146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor activity and toxicity of the degradation products and the aquated species of cis-dichlorodiammineplatinum (II)].
    Takahashi K; Nishikawa K; Kita M; Nakayama Y; Sakakibara T; Ito K; Tsubosaki M; Konoha N
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):616-23. PubMed ID: 6892195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of cisplatin on cultured glioma cells].
    Honda C; Tabuchi K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1921-6. PubMed ID: 3707152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of free radical in podophyllic acid piperindyl hydrazone nitroxide radical on its antitumor activity and toxicity.
    Jia ZP; Wang R; Xie JW; Xu LT
    Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):571-6. PubMed ID: 10678157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluorometric investigations on the cell cycle progression of experimental ascites tumors treated with alkaloidic drugs.
    Stöhr M; Fischinger W
    Arzneimittelforschung; 1978; 28(6):977-81. PubMed ID: 582007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
    Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle effects of CC-1065.
    Bhuyan BK; Crampton SL; Adams EG
    Cancer Res; 1983 Sep; 43(9):4227-32. PubMed ID: 6871861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of tumor cell growth and effects of antitumor drugs on cell cycle regulation by flow cytometry].
    Shinomiya N; Katsura Y; Tsugita M; Noritake M; Tsuru S
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2109-15. PubMed ID: 1888181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin-induced apoptosis in laryngeal squamous cell carcinoma strain and the influence on cell cycle].
    Qi F; Zhang B; Xu Y
    Zhonghua Yi Xue Za Zhi; 1999 Apr; 79(4):298-301. PubMed ID: 11601059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 208.